Brian Kuester
Former U.S. Attorney
Lynette Byrd
Former Assistant
U.S. Attorney
John Sellers
Former DOJ
U.S. Attorney
Joe Brown
Former U.S. Attorney
(Local Counsel)
Dr. Nick Oberheiden
Attorney & Founder
FDA Acknowledgement Form Concerning Violations of 21 U.S.C. Section 331
Recently, the U.S. Food and Drug Administration (FDA) has been having doctors sign forms acknowledging that their prescription drug practices could violate 21 U.S.C. Section 331 and other federal laws. As a physician, you do your best to comply with the law, and the last thing you want to do...
Read more
CBD Compliance for Pharmacists
More patients are coming to you every day asking about CBD oil and other cannabis-based treatments and medications. Here’s what you need to know in order to maintain federal compliance. When the federal Agriculture Improvement Act of 2018 (commonly known as the “Farm Bill”) was passed late last year, hemp...
Read more
How Can Pharmacists Be Charged with Prescription Drug Fraud?
Pharmacists are currently at high risk for being targeted in Federal Healthcare Fraud investigations. If your pharmacy or compound pharmacy is under investigation, we can help. When you went to pharmacy school, the last thing on your mind was the risk of being targeted in a federal investigation. As you...
Read more
What Is the Prescription Interdiction & Litigation (PIL) Task Force?
The Prescription Interdiction & Litigation (PIL) Task Force is one of the DOJ's newest efforts to target healthcare providers as it seeks to combat the nation's opioid crisis. Earlier this year, the U.S. Department of Justice (DOJ) announced the formation of a new Prescription Interdiction & Litigation (PIL) Task Force....
Read more